Neuroscience
FDA approves new Alzheimer’s medication
Lecanemab, a new Alzheimer’s medication shown to slow cognitive decline in patients, has been granted accelerated approval by the FDA.
Genetic research confirms your dog’s breed influences its personality — but so do you
A dog's breed has a big impact on their personality, but whether they fit your lifestyle is also down to good training.
The “recovery paradox” explains why you’re burnt out
There's regular job stress, and then there's uncertainty, dread, and constant change. Here's how to actually recover from it.
How to use the brain’s own immune cells to stave off Alzheimer’s
Research suggests that microglia play a key role in preventing neurodegenerative diseases by helping to remove toxic waste.
Neuroscientists recommend more carbs and less coffee to combat seasonal depression
Taking small steps to help your circadian rhythm adjust to winter could mean happier times during what are literally the darkest days.
Researchers have developed a way to “decode” depression
Baylor College of Medicine researchers have developed an electrode-based “mood decoder” capable of mapping brain activity to mood.
MIT is testing light and sound to combat Alzheimer’s
MIT researchers are developing a therapy that uses 40-Hz light and sound to alter Alzheimer’s patients’ gamma waves.
AI-based theory explains your weird dreams
Researchers suggest that dreaming helps us generalize our experiences so that we can adapt to new circumstances.
How exercise changes your brain biology and protects your mental health
A psychiatrist and neuroscientist began to think of prescribing exercise as telling patients to take their “exercise pills.”